-Douglas T Golenbock Researcher Activity Profile

Research Author Detailed Information 

Douglas T Golenbock Publication Rate By Year

Douglas T Golenbock has published 1 paper(s) in 2005, 3 paper(s) in 2006, 7 paper(s) in 2007, 9 paper(s) in 2008, for a total of 20 research publications in total.

Douglas T Dt Golenbock Author Information

LAST NAME: golenbock

FIRST NAME: Douglas T

INITIALS: dt

AFFILIATION:

Papers

Douglas T Golenbock's Publication Record

1. Toll-like receptor-dependent discrimination of streptococci. Year Published: 2006
Division of Infectious Diseases, Children's Hospital, Freiburg University, Freiburg, Germany.
2. Flavivirus activation of plasmacytoid dendritic cells delineates key elements of TLR7 signaling beyond endosomal recognition. Year Published: 2006
Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01655, USA. jennifer.wang@umassmed.edu
3. MD-2 expression is not required for cell surface targeting of Toll-like receptor 4 (TLR4). Year Published: 2006
Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, NRB, 370L, 364 Plantation Street, Worcester, MA 01605, USA. alberto.visintin@umassmed.edu
4. Innate immune responses to endosymbiotic Wolbachia bacteria in Brugia malayi and Onchocerca volvulus are dependent on TLR2, TLR6, MyD88, and Mal, but not TLR4, TRIF, or TRAM. Year Published: 2007
Center for Global Health and Diseases and Department of Ophthalmology, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 44106, USA. amy.hise@case.edu
5. Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. Year Published: 2007
Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
6. MyD88-dependent activation of dendritic cells and CD4(+) T lymphocytes mediates symptoms, but is not required for the immunological control of parasites during rodent malaria. Year Published: 2007
7. Activation of TLR2 and TLR4 by glycosylphosphatidylinositols derived from Toxoplasma gondii. Year Published: 2007
8. YopJ targets TRAF proteins to inhibit TLR-mediated NF-kappaB, MAPK and IRF3 signal transduction. Year Published: 2007
Division of Infectious Diseases and Immunology, Departments of Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA.
9. Corrigendum: Ligand-induced conformational changes allosterically activate Toll-like receptor 9. Year Published: 2007
10. Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105. Year Published: 2005
Division of Molecular Immunology, Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, Ohio 45229, USA.
11. Failure of TLR4-Driven NF-kappaB Activation to Stimulate Virus Replication in Models of HIV Type 1 Activation. Year Published: 2008
Center for Comparative Medicine and Translational Research and Department of Molecular Biomedical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina 27606.
12. Failure of TLR4-driven NF-kappa B activation to stimulate virus replication in models of HIV type 1 activation. Year Published: 2008
Center for Comparative Medicine and Translational Research, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina 27606, USA.
13. Failure of TLR4-driven NF-kappa B activation to stimulate virus replication in models of HIV type 1 activation. Year Published: 2008
Center for Comparative Medicine and Translational Research, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina 27606, USA.
14. Cathepsin K-dependent toll-like receptor 9 signaling revealed in experimental arthritis. Year Published: 2008
Department of Cell Signaling, Graduate School, Tokyo Medical and Dental University, Tokyo 113-8549, Japan.
15. The Differential Impact of Disulfide Bonds and N-Linked Glycosylation on the Stability and Function of CD14. Year Published: 2008
Department of Physiology and Biophysics, Boston University School of Medicine, Boston, Massachusetts 02118.
16. YopJ targets TRAF proteins to inhibit TLR-mediated NF-kappaB, MAPK and IRF3 signal transduction. Year Published: 2007
Division of Infectious Diseases and Immunology, Departments of Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA.
17. Cathepsin K-dependent toll-like receptor 9 signaling revealed in experimental arthritis. Year Published: 2008
Department of Cell Signaling, Graduate School, Tokyo Medical and Dental University, Tokyo 113-8549, Japan.
18. Lipoteichoic Acid-Induced Lung Inflammation Depends on TLR2 and the Concerted Action of TLR4 and the Platelet-Activating Factor Receptor. Year Published: 2008
Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands;
19. MUC1 mucin is a negative regulator of toll-like receptor signaling. Year Published: 2008
Lovelace Respiratory Research Institute, 2425 Ridgecrest Dr., S.E., Albuquerque, NM 87108-5127, USA.
20. The differential impact of disulfide bonds and N-linked glycosylation on the stability and function of CD14. Year Published: 2008
Department of Physiology and Biophysics, Boston University School of Medicine, Boston, Massachusetts 02118, USA.